Market revenue in 2023 | USD 70.3 million |
Market revenue in 2030 | USD 137.0 million |
Growth rate | 10% (CAGR from 2023 to 2030) |
Largest segment | Dogs |
Fastest growing segment | Cats |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dogs, Cats |
Key market players worldwide | Merck & Co Inc, Zoetis, BD, Boehringer Ingelheim, ACON Laboratories, Taidoc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pet diabetes care market will help companies and investors design strategic landscapes.
Dogs was the largest segment with a revenue share of 52.35% in 2023. Horizon Databook has segmented the China pet diabetes care market based on dogs, cats covering the revenue growth of each sub-segment from 2018 to 2030.
The China pet diabetes care market is expected to register notable growth in the near future. This is owing to key factors such as significant population of companion animals, presence of local companies, increasing pet expenditure, and growing availability of diabetes products.
Horizon Databook provides a detailed overview of country-level data and insights on the China pet diabetes care market , including forecasts for subscribers. This country databook contains high-level insights into China pet diabetes care market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account